ScienceDaily Health
Scientists reveal the best exercise for knee arthritis pain relief
A major review of 217 trials shows that aerobic exercise is the most effective option for managing knee osteoarthritis. Activities like walking, cycling, and swimming outperformed other exercise types in reducing pain and improving movement. While alternatives like strength training and mind-body exercises help, they are best used alongside aerobic workouts. The findings also confirm that exercise is a safe and essential part of treatment.
This AI knew the answers but didn’t understand the questions
For decades, psychologists have debated whether the human mind can be explained by one unified theory or must be broken into separate parts like memory and attention. A recent AI model called Centaur seemed to offer a breakthrough, claiming it could mimic human thinking across 160 different cognitive tasks. But new research is challenging that bold claim, suggesting the model isn’t truly “thinking” at all—it’s just memorizing patterns.
A hidden map in your nose could explain how smell works
Scientists have finally cracked one of the biggest mysteries in the senses: how smell is organized. By mapping millions of neurons in mice, researchers discovered that smell receptors in the nose aren’t random at all—they’re arranged in neat, overlapping stripes based on receptor type, forming a hidden structure scientists never knew existed. Even more striking, this layout mirrors how smell information is mapped in the brain, revealing a coordinated system from nose to neural circuits.
First-ever 3D view shows how killer T cells destroy cancer
The body’s “killer” T cells don’t just attack—they strike with astonishing precision, forming a tiny, highly organized contact zone that lets them destroy dangerous cells without harming their neighbors. Now, scientists have captured this process in unprecedented detail, revealing a hidden world of molecular choreography.
A forgotten drug is giving new hope to kids with a rare disease
A decades-old drug once used to treat sleeping sickness is now showing surprising promise against an ultra-rare and life-threatening genetic disorder called Bachmann-Bupp syndrome (BABS). Early patient treatments suggest the drug, DFMO, may ease severe symptoms by targeting the underlying genetic malfunction. Researchers have already treated a handful of patients with encouraging results, but progress has been slowed by regulatory and logistical hurdles.
Top stories featured on ScienceDaily's Health & Medicine, Mind & Brain, and Living Well sections.
Subscribe to ScienceDaily Health feed